期刊文献+

Exendin-4对糖尿病脑缺血再灌注大鼠脑组织中MMP-9表达的影响 被引量:2

Effect of Exendin-4 on Expression of Brain Tissue MMP-9 After Cerebra Ischemia-reperfusion Injury in Diabetic Rats
原文传递
导出
摘要 目的:通过观察Exendin-4对糖尿病大鼠脑缺血再灌注后脑梗死体积百分比及脑组织中金属基质蛋白酶-9及基质金属蛋白酶抑制剂-1的变化,探讨Exendin-4对糖尿病大鼠脑缺血再灌注损伤的保护作用机制。方法:选用SD大鼠,给予链脲佐菌素(streptozocin,STZ)建立糖尿病大鼠模型后,随机分为A组:糖尿病对照组(n=6);B组:模型组(n=6);C组:Exendin-4低剂量组(n=6);D组:Exendin-4中剂量组(n=6);E组:Exendin-4高剂量组(n=6)。常规喂养6周后,A组给予假手术处理,B、C、D及E组采用线栓法制作大鼠大脑中动脉缺血90 min再灌注模型,24 h后处死大鼠取脑组织,采用2,3,5一氯化三苯四唑(2,3,5-triphenyltetrazolium chloride,TTC)染色测算脑梗死体积百分比;同时分别采用Western Blot法及RT-PCR测量脑组织中的MMP-9及TIMP-1表达量。结果:脑缺血再灌注能致脑组织中MMP-9及TIMP-1表达量增高,各组与A组比较,有显著差异(P<0.05);给予Exendin-4处理后脑组织中MMP-9及TIMP-1表达增高程度及脑梗死体积百分比明显降低,与B组比较有显著差异(P<0.05)。结论:Exendin-4对糖尿病大鼠脑缺血再灌注损伤有保护作用,其机制可能与抑制MMP-9及TIMP-1的表达有关。 Objective: To investigate the protective mechanism of Exendin-4 against cerebral ischemia-reperfusion induced injury in diabetic rats.Methods: The rat model of diabetes mellitus was set up by streptozocin(STZ).The diabetic SD rats were randomly divivded into five groups: diabetes control group(Group A,n=6),model group(Group B n=6),Exendin-4 low-dose group(Group C n=6),Exendin-4 moderate-dose group(Group D n=6),Exendin-4 high-dose group(Group E n=6).Group A was subjected to a sham operation,and other groups were subjected to left middle cerebral artery occlusion for 90 minutes after all rats fed by normal diet six weeks.All rats were killed 24 hours after postoperation,and brain tissue was obtained.The effects of Exendin-4 on the brain was analyzed by detecting the infarct volume and the expression of MMP-9,TIIP-1 through 2,3,5-triphenyltetrazolium chloride(TTC)staining,Western Blot and RT-PCR.Results: Cerebral ischemia-reperfusion injury can increase the expression of brain tissue MMP-9 and TIMP-1.The expression of MMP-9,TIIP-1 increased significantly in Group B,Group C,Group D and Group E,compared with that in Group A(P0.05).The expression of MMP-9,TIIP-1 reduced significantly in Exendin-4 treatment group,compared with that in Group B(P0.05).Conclusion: Exendin-4 protect against cerebral ischemia-reperfusion induced injury in diabetic rats,and the mechanism may be related with the inhibition of the MMP-9 and TIMP-1expression.
出处 《现代生物医学进展》 CAS 2012年第15期2859-2862,共4页 Progress in Modern Biomedicine
关键词 EXENDIN-4 金属基质蛋白酶-9 糖尿病 脑缺血再灌注 Exendin-4 Matrix metalloproteinase-9 Diabetes Cerebra Ischemia-reperfusion
  • 相关文献

参考文献13

  • 1Edwards CM, Stanley SA, Davis R, et al. Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers[J]. Am J Physiol Endocrinol Metab, 2001, 281:155-161.
  • 2Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats [J]. Stroke, 1989, 20(1 ): 84-91.
  • 3Nystrom T, Gutniak MK, Zhang Q, et al. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease [J]. Am J Physiol Endocrinol Metab, 2004, 287(6)I E1209-1215.
  • 4Y Shigemori, Y Katayama, T Mori, et al. Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats [J]. Acta Neurochirurgica Supplementum, 2006, 96(5): 130-133.
  • 5Li YZ, Tracy AP, Mark S, et al. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism[J]. PNAS, 2009,106 (4): 1285-1290.
  • 6Wang CX, Shuaib A. Involvement of inflammatory cytokines in central nervous system injury [J]. Prog Neurobiol, 2002, 67(2): 161 - 172.
  • 7Magnoni S, Baker A, George S J, et al. Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice [J]. Neurobiology of Disease, 2004, 17 (2): 188-197.
  • 8全冠民.MMPs,TIMPs与缺血后血管源性脑水肿[J].国外医学(生理病理科学与临床分册),2002,22(3):281-283. 被引量:7
  • 9Bullock BP, Heller RS, Habener JE. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor[J]. Endocrinology, 1996, 137(7): 2968-2978.
  • 10Eng J, Kleinman WA, Singh L, et al. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas[J]. J Biol Chem, 1992, 267:' 7402-7405.

二级参考文献21

  • 1Neumann-ttaefelin T, Kastrup A, Crespigny A, et al. Serial MRI after transient focal cerebral ischemia in rats, dynamics of tissue injury, bloodbrain barrier damage, and edema formaton [ J ]. Stroke, 2000,31 (8): 1968- 1973.
  • 2Romanic AM,White RF,Arleth AJ, et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats, inhibition of matrix metalloproteinase-9 reduces infarct size [J]. Stroke, 1998,29 (5):1020- 1030.
  • 3Jiang X, Namura S, Nagata I. Matrix metalloproteinase inhibitor KB-7785 attenuate brain damage resulting from permanent focal cerebral ischemia in mice[J]. Neurosci Lett,2001,305( 1 ) :41 - 44.
  • 4Harkness KA, Adamson P, Sussman JD, et al. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium[J].Brain, 2000,1123: 698 - 709.
  • 5Cary DJ. Control of growth and differentiation of vascular cells by extracellular matrix protein[J] .Ann Rev Physiol,1991,53:161 - 177.
  • 6Fujimura M, Gasche Y, Morita- Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion[J]. Brian Res, 1999,842(1) :92- 100.
  • 7Rosenberg GA, Estrada BS, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain[J]. Stroke, 1998,29(10) :2189 - 2195.
  • 8Gasche Y, Fujimura M, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice:a possible role in blood-brain barrier dysfunction[ J]. J Cereb Bloob Flow Metab, 1999,19(9): 1020 - 1028.
  • 9Asahina M, Yoshiyama Y, Hattori T. Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's diseasr brain[J]. Clin Neuropathol, 2001 ,20(2) :60 - 63.
  • 10Heo JH, Lucero J, Abumiya T, et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia[J] .J Cereb Blood Flow Metab, 1999,1996(6) :624 - 633.

共引文献6

同被引文献37

  • 1梁晓春.糖尿病脑病与中医补肾法对脑保护作用的思考[J].中医杂志,2005,46(5):329-331. 被引量:17
  • 2中国防治认知功能障碍专家共识专家组.中国防治认知功能障碍专家共识[J].中华内科杂志,2006,45(2):171-173. 被引量:569
  • 3田国庆.糖尿病脑病与消渴病兼证“呆症”及其中医治疗[J].中国临床医生杂志,2006,34(5):12-13. 被引量:14
  • 4潘善余.益肾化痰祛瘀法治疗糖尿病脑病证治探讨[J].浙江中医杂志,2006,41(10):594-594. 被引量:4
  • 5Wang XH,Li L,HOlscher C,et al.Val8-glucagon like peptide-1 protects against AI31-40-induced impairment of hippocampal latephase long-term potentiation and spatial learning in rats[J].Neuroscience,2010,(170):1239-1248.
  • 6Alkhenizan AH,Alswes MA.The role of renin blockers in the prevention of diabetes [J].Saudi Med J,2007,(28):91- 95.
  • 7Hutchinson DS,Summers RJ,Bengtsson T.Regulation of AMPactivated protein kinase activity by G-protein cou- pled receptors:potential utility in treatment of diabetes and heart disease[J].Pharmacol Ther,2008,1(19):291-310.
  • 8Delgado-Rubtn A,Chowen JA,Argente J,et al.Growth hormone releasing peptide 6 protection of hypothalamic neurons from glutamate excitotoxicity is caspase indepen- dent and not mediated by insulin-like growth factor I[J]. Eur J Neurosci, 2009,(29) : 2115-2124.
  • 9王斌,吴深涛.糖尿病脑病的中医药治疗研究进展[J].心理医生杂志,2012.18(7):474-475.
  • 10袁国桢,季向东,王群松,等.补肾祛瘀益智汤治疗糖尿病认知功能障碍临床研究[C].第十二届全国中西医结合精神疾病学术会议论文集,2013:23-26.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部